Randy D. Chatman Named New CEO of ThermoTek: 25 Years of Medical Device Operating Experience

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

April 14, 2021

Randy D. Chatman experience in key leadership roles for global industry bellwethers, include Wright Medical Group (acquired by Stryker), Covidien (acquired by Medtronic), Johnson & Johnson, and others.

“I’m honored to be named CEO of ThermoTek,” said Chatman. “Thermotek is in a unique position to launch new product lines, grow into adjacent medical and industrial markets and acquire complementary private companies.”

Before joining ThermoTek, Chatman served as the Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access for Wright Medical Group, a global medical device company focused on extremities and biologics which recently sold to Stryker for $4.7 billion. He brings a wealth of expertise in the medical products space and will guide ThermoTek through its next phase of growth as it continues innovating and delivering post-orthopedic recovery solutions across the globe.

“We are thrilled to have Randy join the ThermoTek team. Randy’s deep knowledge of the medical device industry, highly-regarded leadership and proven expertise in scaling businesses makes us confident he is the right executive to lead ThermoTek’s next chapter of growth,” commented Christopher W. Kersey, M.D., M.B.A., Founding Managing Partner of Havencrest Capital Management.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.